News
- August 6, 2025
- Ginger Vieira
First “Gene-Edited” Islet Cell Survives 12 Weeks in T1D Man
News
- July 21, 2025
- Ginger Vieira
SAB Bio Secures Funding to Run T1D Clinical Trial in the USA
News
- June 23, 2025
- Ginger Vieira
Sana Biotechnology Shares Results Using Hypoimmune Islet Cells
News
- June 20, 2025
- Ginger Vieira
Vertex Shares Update on VX-880 Clinical Trial at ADA Scientific Sessions
News
- June 10, 2025
- Ginger Vieira
Tandem & Abbott Partner to Develop Technology that Measures Glucose & Ketones
Healthcare
- May 21, 2025
- Ginger Vieira
Breakthrough T1D Submits Application to Make T1D Screening Routine Care
Insulin
- May 10, 2025
- Ginger Vieira
Inhaled Insulin in Kids? Clinical Trial Update
News
- April 29, 2025
- Ginger Vieira
Eversense Announces Insulin Pump Partnership
GLP-1
- April 6, 2025
- Ginger Vieira
Eli Lilly Studying Tirzepatide in People with Type 1 Diabetes
Search on blog
Post List
-
Cancer Drug Triggers Insulin Production in T1D
January 3, 2024 By Ginger Vieira -
Vertex VX-880 and VX-264 Clinical Trial Updates
September 25, 2024 By Ginger Vieira -
20 Percent Reduction in Post-Meal Blood Sugar
March 11, 2025 By Ginger Vieira
Categories
TAG CLOUD
autoantibodies
Blog
Business
cgm
cure research
diabetes
diabetes research
diabetes technology
diamyd
Digital
eversense
fda
gene editing
genetic risk
glp-1
heart health
hypoimmune islet cells
immunomodulator
inhaled insulin
insulin
insulin research
ketones
Mental Health
mounjaro
obesity
ozempic
risk of type 1 diabetes
sana biotechnology
screening
semaglutide
senseonics
sequel medtech
T1D genetics
t1d risk
Tech
tirzepatide
twiist
type 1 diabetes
type 1 diabetes diagnosis
type 1 diabetes prevention
type 2 diabetes
vertex
wegovy
weight loss
Wordpress
